Patents by Inventor Thomas McCann

Thomas McCann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220031950
    Abstract: Systems and methods for diabetes management with automatic basal and manual bolus insulin control are presented. An exemplary system includes a delivery device, a glucose sensor, and a controller. The delivery device delivers insulin and the glucose sensor measures glucose levels of the subject. A basal insulin dose is calculated using a model predictive control algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels. A manual bolus insulin dose is initiated by the subject. The manual bolus insulin dose is modified based on one or both of the model predictive control algorithm and the physiological data of the subject. A total insulin dose is determined based on the modified manual bolus insulin dose and the calculated basal insulin dose, and delivered to the subject.
    Type: Application
    Filed: October 18, 2021
    Publication date: February 3, 2022
    Inventors: Daniel Finan, Thomas McCann
  • Publication number: 20210270293
    Abstract: A control valve assembly for a load handling vehicle such as forklift comprises a valve body having a bore and a spool located within the bore that is axially movable along the bore between at least two operating configurations. The valve body includes a service port connected to a hydraulic actuator, a pressure port connected to a pump, and a tank port connected to a hydraulic tank reservoir. The valve is reconfigurable between first and second operating configurations. In the first operating configuration the spool defines a fluid pathway connecting the pump port, the service port and the tank port such that in a first flow direction fluid is able to flow from the pressure port to the service port and the tank port, and in a second flow direction fluid is able to flow from the service port to the pressure port and the tank port. The spool is also controllable in the first operating configuration to variably restrict flow to the tank port.
    Type: Application
    Filed: July 11, 2019
    Publication date: September 2, 2021
    Inventors: Andries Broekx, Paul Leadly, Thomas McCann
  • Publication number: 20210270294
    Abstract: A hydraulic system (1, 50) for a load handling vehicle comprises lifting actuator (2, C1) that operates in a load lifting mode in which a load is induced on the actuator, and a load lowering mode in which the actuator provides hydraulic power PI to the hydraulic system. An auxiliary hydraulic actuator (4, 6, 8, C2) is also provided that has a hydraulic power demand P2. A hydraulic pump (10, 58) directs hydraulic power to the hydraulic lifting actuator and the at least one auxiliary hydraulic actuator.
    Type: Application
    Filed: July 11, 2019
    Publication date: September 2, 2021
    Inventors: Andries Broekx, Paul Leadly, Thomas McCann
  • Publication number: 20180147349
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed to switchover from one mode of MPC control based on a predetermined range of blood glucose values to another MPC mode based on a predetermined target.
    Type: Application
    Filed: January 29, 2018
    Publication date: May 31, 2018
    Inventors: Daniel FINAN, Thomas MCCANN
  • Publication number: 20180147348
    Abstract: The invention provides for disabling of the audio bolus feature of a drug delivery system on the occurrence, or predicted occurrence, of certain events mitigating the problem of a user delivering unneeded drug. The invention provides a drug delivery system having at least one controller configured to autonomously modulate drug delivery from the drug delivery device, a sensor for measuring an analyte of the user, and an audio bolus feature, wherein the audio bolus feature is automatically disabled if the controller determines a therapeutically significant state is present.
    Type: Application
    Filed: November 27, 2017
    Publication date: May 31, 2018
    Inventors: Thomas MCCANN, Daniel FINAN, Anthony DIUBALDI, Brian LEVY
  • Patent number: 9975426
    Abstract: An electric vehicle comprises an electrical system and a hydraulic system. The electrical system comprises an electric power supply and an electric motor-generator connected to the drive train of the vehicle. The hydraulic system includes a pump, and a hydraulic actuator. At least one of the electrical system and the hydraulic system includes energy recovery means arranged to convert kinetic energy from the drive train to electrical energy or to convert kinetic energy from the hydraulic actuator into hydraulic pressure respectively. The electrical and hydraulic systems are connected such that the recovered energy may be converted from electrical to hydraulic energy and/or vice versa. The hydraulic system may further include a hydraulic accumulator.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: May 22, 2018
    Assignee: PARKER-HANNIFIN MANUFACTURING LIMITED
    Inventor: Thomas McCann
  • Patent number: 9907909
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed to switchover from one mode of MPC control based on a predetermined range of blood glucose values to another MPC mode based on a predetermined target.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: March 6, 2018
    Assignee: Animas Corporation
    Inventors: Daniel Finan, Thomas McCann
  • Publication number: 20180043095
    Abstract: Methods and systems for controlling an insulin pump in response to glucose measurements are responsive to a base insulin delivery profile and a temporary insulin delivery profile. These can be used, e.g., to control blood glucose level of a subject using a continuous glucose monitor and an insulin infusion pump. During a selected time range, an insulin amount for the pump to supply is determined using the temporary insulin delivery profile. Outside that time range, the insulin amount is determined using the base insulin delivery profile. The temporary insulin delivery profile can specify an exact amount to be supplied (a “hard” profile), a nominal amount to be supplied if doing so does not drive glucose out of a desired zone (“soft”), or a soft profile with a minimum amount of insulin to be delivered (“semi-soft”).
    Type: Application
    Filed: October 3, 2017
    Publication date: February 15, 2018
    Inventors: Daniel FINAN, Thomas MCCANN
  • Patent number: 9795737
    Abstract: Methods and systems for controlling an insulin pump in response to glucose measurements are responsive to a base insulin delivery profile and a temporary insulin delivery profile. These can be used, e.g., to control blood glucose level of a subject using a continuous glucose monitor and an insulin infusion pump. During a selected time range, an insulin amount for the pump to supply is determined using the temporary insulin delivery profile. Outside that time range, the insulin amount is determined using the base insulin delivery profile. The temporary insulin delivery profile can specify an exact amount to be supplied (a “hard” profile), a nominal amount to be supplied if doing so does not drive glucose out of a desired zone (“soft”), or a soft profile with a minimum amount of insulin to be delivered (“semi-soft”).
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 24, 2017
    Assignee: ANIMAS CORPORATION
    Inventors: Daniel Finan, Thomas McCann
  • Patent number: 9486578
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed receives signals from at least one of the glucose sensor and the pump and configured to issue signals to the pump to deliver an amount of insulin determined by a feedback controller that utilizes a model predictive control of the subject based on desired glucose levels, insulin amount delivered and measured glucose levels of the subject. The controller is also configured to deliver insulin using a tuning factor based on either one of an omission index module or a calibration index module.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: November 8, 2016
    Assignee: Animas Corporation
    Inventors: Daniel Finan, Thomas McCann, Ramakrishna Venugopalan
  • Patent number: 9474855
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed in the controller. The infusion pump is configured to deliver insulin. The glucose sensor senses glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed receives signals from at least one of the glucose sensor and the pump and configured to issue signals to the pump to deliver an amount of insulin determined by a feedback controller that utilizes a model predictive control based on desired glucose levels, insulin amount delivered and measured glucose levels of the subject. The controller is also configured to deliver insulin using a tuning factor (R) for a model predictive controller in the microcontroller as a conservative setting otherwise the system maintains a current tuning factor (R) for the controller.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: October 25, 2016
    Assignee: Animas Corporation
    Inventors: Thomas McCann, Thomas Schaible, Jorge Capurro
  • Publication number: 20160152138
    Abstract: An electric vehicle comprises an electrical system and a hydraulic system. The electrical system comprises an electric power supply and an electric motor-generator connected to the drive train of the vehicle. The hydraulic system includes a pump, and a hydraulic actuator. At least one of the electrical system and the hydraulic system includes energy recovery means arranged to convert kinetic energy from the drive train to electrical energy or to convert kinetic energy from the hydraulic actuator into hydraulic pressure respectively. The electrical and hydraulic systems are connected such that the recovered energy may be converted from electrical to hydraulic energy and/or vice versa. The hydraulic system may further include a hydraulic accumulator.
    Type: Application
    Filed: June 26, 2014
    Publication date: June 2, 2016
    Inventor: Thomas McCann
  • Publication number: 20160082187
    Abstract: A decision support system includes a measurement device configured to continuously measure a physiological parameter of a patient. An insulin delivery device provides insulin to the patient per an initial basal profile and the parameter measurements. A storage device holds historical data of insulin delivery to the patient. A processor determines deviations of the delivery of insulin from the basal profile for one or more time period(s) using the historical data, computes a respective first basal-profile adjustment for each of the one or more time period(s) using the determined deviations, and annunciates the computed first basal-profile adjustment(s). A method of recommending a basal-rate adjustment includes measuring the parameter, infusing the patient with insulin and storing the historical data, determining the deviations from the basal profile, computing the first basal-profile adjustments, and annunciating the computed first basal-profile adjustment(s).
    Type: Application
    Filed: September 23, 2014
    Publication date: March 24, 2016
    Inventors: Thomas SCHAIBLE, Thomas MCCANN, Jorge CAPURRO
  • Publication number: 20150100038
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed in the controller. The infusion pump is configured to deliver insulin. The glucose sensor senses glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed receives signals from at least one of the glucose sensor and the pump and configured to issue signals to the pump to deliver an amount of insulin determined by a feedback controller that utilizes a model predictive control based on desired glucose levels, insulin amount delivered and measured glucose levels of the subject. The controller is also configured to deliver insulin using a tuning factor (R) for a model predictive controller in the microcontroller as a conservative setting otherwise the system maintains a current tuning factor (R) for the controller.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 9, 2015
    Applicant: Animas Corporation
    Inventors: Thomas McCann, Thomas Schaible, Jorge Capurro
  • Publication number: 20140276554
    Abstract: Methods and systems for controlling an insulin pump in response to glucose measurements are responsive to a base insulin delivery profile and a temporary insulin delivery profile. These can be used, e.g., to control blood glucose level of a subject using a continuous glucose monitor and an insulin infusion pump. During a selected time range, an insulin amount for the pump to supply is determined using the temporary insulin delivery profile. Outside that time range, the insulin amount is determined using the base insulin delivery profile. The temporary insulin delivery profile can specify an exact amount to be supplied (a “hard” profile), a nominal amount to be supplied if doing so does not drive glucose out of a desired zone (“soft”), or a soft profile with a minimum amount of insulin to be delivered (“semi-soft”).
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Daniel Finan, Thomas McCann
  • Publication number: 20140180240
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed to switchover from one mode of MPC control based on a predetermined range of blood glucose values to another MPC mode based on a predetermined target.
    Type: Application
    Filed: December 20, 2012
    Publication date: June 26, 2014
    Applicant: Animas Corporation
    Inventors: Daniel FINAN, Thomas McCANN
  • Publication number: 20140163517
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed receives signals from at least one of the glucose sensor and the pump and configured to issue signals to the pump to deliver an amount of insulin determined by a feedback controller that utilizes a model predictive control of the subject based on desired glucose levels, insulin amount delivered and measured glucose levels of the subject. The controller is also configured to deliver insulin using a tuning factor based on either one of an omission index module or a calibration index module.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 12, 2014
    Applicant: Animas Corporation
    Inventors: Daniel FINAN, Thomas McCANN, Ramakrishna Venugopalan
  • Publication number: 20130233298
    Abstract: The invention provides a readily deployed insulating seal for the hearth opening eliminating airflow to and from the chimney flue that utilizes a safe and uncomplicated expanding Pneumatic filled mass that acts as a closure preventing heat loss from exiting the room and blocking cold air from entering.
    Type: Application
    Filed: March 8, 2012
    Publication date: September 12, 2013
    Inventor: Thomas McCann
  • Patent number: 8453609
    Abstract: The pet toy of the present invention comprises a light weight body and a pet treat dispenser for dispensing a treat to a pet animal upon accessing the pet toy with the pet treat dispenser affixed to the body at a location at or substantially close to the center of gravity of the pet toy and comprising a flexible material divided into at least two sections with each section including one or more layers of flexible material extending from a border area surrounding the perimeter of the pet treat dispenser such that the flexible layer(s) form a plurality of flaps for removably gripping the pet treat.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: June 4, 2013
    Inventor: Thomas McCann
  • Patent number: D689951
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: September 17, 2013
    Inventors: Thomas McCann, Mark Grochala